Internship
Software Engineer Intern
Lab Systems
Confirmed live in the last 24 hours
Neuralink
201-500 employees
Develops brain-computer interfaces for medical use
Compensation Overview
$35Hourly
Fremont, CA, USA
- Demonstrated experience in shipping a product that has been actively used, regardless of tech stack or domain (e.g., full-stack, machine learning, etc.)
- Ability to design and implement simple and elegant software solutions
- Proven track record of shipping software with real-world impact
- Enthusiasm for technology and software
- Understanding of how systems work at a fundamental level
- ERP software that orchestrates and tracks everything involved designing and manufacturing brain-machine interfaces
- Data platforms to collect, organize, and visualize a diverse set of data ranging from neural signal recordings, device telemetries, surgery recordings, to manufacturing data
- Lab Systems software, our digital collaboration hub for all teams within the company
- Devops and infrastructure to increase developer productivity
- Familiarity with Ruby, Python, and/or JavaScript
- Experience with C/C++/Rust
- Knowledge of container management and orchestration
- Experience with full-stack application frameworks like Ruby on Rails or Django
- Understanding of web development
- Experience with infrastructure development
Neuralink develops brain-computer interfaces (BCIs) that enable direct communication between the brain and external devices. Their main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices. It works by processing neural signals with low-power chips and transmitting the data wirelessly to an application that translates brain activity into commands. What sets Neuralink apart from competitors is its focus on both medical applications for individuals with mobility issues and the potential for cognitive enhancement for a broader audience. The company's goal is to restore autonomy to those with unmet medical needs while exploring the possibilities of human-computer interaction.
Company Size
201-500
Company Stage
Series D
Total Funding
$667.3M
Headquarters
Fremont, California
Founded
2016
Simplify's Take
What believers are saying
- Neuralink's partnership with University of Miami enhances clinical trial opportunities for the N1 Implant.
- Regulatory approval in Canada expands Neuralink's market reach for brain-computer interfaces.
- Advancements in AI algorithms could enhance the performance of Neuralink's N1 Implant.
What critics are saying
- Increased competition from Paradromics threatens Neuralink's market share in brain-computer interfaces.
- SEC investigation into Neuralink could lead to legal and financial repercussions.
- Development of Blindsight device may divert resources from the N1 Implant.
What makes Neuralink unique
- Neuralink's N1 Implant is a fully implantable, cosmetically invisible brain-computer interface.
- The R1 Robot enables precise, minimally invasive implantation of ultra-thin electrode threads.
- Neuralink's technology translates brain activity into computer commands, restoring autonomy to users.
Help us improve and share your feedback! Did you find this helpful?
Benefits
An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.
Growth potential. We rapidly advance team members who have an outsized impact.
Excellent medical, dental, and vision insurance through a PPO plan; parental leave.
Flexible time off + paid holidays.
Equity + 401(k) plan.
Commuter Benefits.
Meals provided.
Growth & Insights and Company News
6 month growth
↑ 2%1 year growth
↑ 1%2 year growth
↑ 2%Neuralink, founded by Elon Musk, is developing a brain-computer interface (BCI) that connects human brains directly to computers.
A brain-computer interface (BCI) startup called Paradromics, a competitor to Elon Musk's Neuralink that's aiming to control computers using brain implants, is partnering with Saudi Arabia's megalomaniac Neom city-building project.
By Nancy DahlbergElon Musk may have Washington on his mind, but his brain chips are headed to Miami.Neuralink, Musk’s startup, has selected the University of Miami’s Miller School of Medicine to be the second US clinical trial site to test whether its brain chip – a brain-computer interface implant – can give people who are paralyzed the ability to use only their thoughts to control their smartphones, computers and other electronic devices.“The Miami Project to Cure Paralysis and the University of Miami are renowned for their pioneering research in neural interfaces for the treatment of debilitating neurological conditions such as spinal cord injury and ALS. We look forward to partnering with them as a site for our PRIME Study,” DJ Seo, co-founder, president and COO at Neuralink, said in a statement.The Neuralink PRIME (Precise Robotically Implanted Brain-Computer Interface) Study will seek to assess the safety and functionality of Neuralink’s N1 Implant. This brain-computer interface (BCI) implant establishes a wireless, digital link between the brain and computers. The study will also evaluate Neuralink’s R1 Robot, a surgical robot that precisely and rapidly places the N1 Implant’s ultra-fine electrode threads within microns of targeted neurons.“This study will use the latest technological advances in BCI approaches for improving function and quality of life in individuals living with the consequences of chronic spinal cord injury, as well as amyotrophic lateral sclerosis (ALS),” said Dr. Allan Levi, a UM professor and chair of neurological surgery and a co-investigator, in the announcement.The implant procedure will be carried out by Neuralink scientists and a multidisciplinary team of neurosurgeons, neuroscientists and biomedical engineers at The Miami Project to Cure Paralysis and the Miller School of Medicine.The procedure is less invasive than other types of brain surgeries because the Neuralink procedure occurs on the superficial surface area of the brain and requires a relatively small incision, he told the Miami Herald. “I really think it’s going to be a game changer.” Neuralink was founded in 2016
Founded by ex-Neuralink co-founder Ben Rapoport, it competes with Elon Musk's Neuralink, which has raised over $685 million.
In 2023, the Physicians Committee for Responsible Medicine and four US lawmakers urged the SEC to investigate Neuralink for possible securities fraud, alleging that the company made misleading claims about its technology.